Search results

From Self-sufficiency
Jump to: navigation, search
  • ...e Beek D, de Gans J, McIntyre P, Prasad K |title=Corticosteroids for acute bacterial meningitis |journal=Cochrane Database Syst Rev |volume= |issue=1 |pages=CD0 * Severe systemic viral, bacterial, and fungal infections
    18 KB (2,498 words) - 16:41, 27 September 2010
  • ...nfections including leprosy, collagen vascular diseases, inflammatory skin diseases and children with impaired immune a variety of reasons. It has also been us
    10 KB (1,350 words) - 16:42, 27 September 2010
  • ...|anaerobic]] [[bacteria]] but can also be used to treat some [[protozoa]]l diseases, such as [[malaria]]. It is a common [[topical]] treatment for [[acne]] and === Bacterial ===
    25 KB (3,261 words) - 14:17, 11 September 2010
  • *[[Acne]] and other inflammatory skin diseases, such as [[hidradenitis suppurativa]] ...ith 1 billion at risk<ref>Watkins, B.M. Drugs for the control of parasitic diseases: current status and development. TRENDS in Parasitology (2003)19:11</ref>.
    20 KB (2,578 words) - 16:43, 27 September 2010
  • ...y.<ref>[http://www.cdc.gov/std/treatment/2006/toc.htm Sexually Transmitted Diseases Treatment Guidelines 2006] Centers for Disease Control and Prevention. MMWR ...he mechanism is not fully understood. By binding to the 50s subunit of the bacterial 70s [[rRNA]] complex, protein synthesis and subsequently structure/function
    19 KB (2,731 words) - 17:52, 18 September 2010
  • The metronidazole metabolites are taken up into bacterial DNA, and form unstable molecules. This function only occurs when metronidaz ===Bacterial===
    19 KB (2,528 words) - 16:43, 27 September 2010
  • ...pg|thumbnail|300px|Crystal structure of a short peptide L-Lys-D-Ala-D-Ala (bacterial cell wall precursor, in green) bound to vancomycin (blue) through hydrogen ...The three peptide synthases are located at the start of the region of the bacterial genome linked with [[antibiotic]] biosynthesis and spans 27kb.<ref name="pm
    31 KB (4,198 words) - 16:43, 27 September 2010
  • ...ds,<ref name="Arbiser"/><ref name="Morrison"/> which are toxic and inhibit bacterial proliferation.<ref>Dennis, E. A. 1983. Phospholipases, p. 307-353. In P. D. ...tle=Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. |journal=Proc Natl Acad Sci U S A. |volume=103 |issue=46 |pages=17414–9
    12 KB (1,651 words) - 16:43, 27 September 2010
  • ...a mechanism for a neuron-sparing effect in inflammatory neurodegenerative diseases such as Alzheimer disease and stroke <ref>{{cite journal |author=Diaz-Ruiz ...tiformis]] and [[Linear immunoglobulin A dermatosis]] both blistering skin diseases which are effectively treated with a long-time treatment with dapsone, as w
    15 KB (2,087 words) - 16:43, 27 September 2010
  • Isoniazid is a [[prodrug]] and must be activated by a bacterial catalase-peroxidase enzyme called KatG.<ref>{{Cite journal|author=Suarez J, ...for international pediatric dosing guidelines |journal=Clinical Infectious Diseases |volume=48 |issue=11 |pages=1547–53 |year=2009 |month=June |pmid=19392636
    12 KB (1,566 words) - 16:43, 27 September 2010
  • ...nthesis inhibitor]]. It binds to the S12 Protein of the 30S subunit of the bacterial ribosome, interfering with the binding of [[formyl-methionyl-tRNA]] to the ...omycin found extensive application in the treatment of numerous infectious diseases. Streptomycin was the first [[antibiotic]] that could be used to cure the d
    9 KB (1,069 words) - 15:06, 6 July 2010
  • .... FDA on 22 October 22 1987 for use in the United States to treat specific bacterial infections. In 1991, the intravenous formulation was introduced. The curren In the adult population, ciprofloxacin is limited to the treatment of proven bacterial infections such as:
    88 KB (11,930 words) - 16:46, 27 September 2010
  • ...pneumonia]] with azithromycin prophylaxis | journal=Journal of Infectious Diseases | year=1998 | volume=177 | pages=161–166 | doi=10.1086/513818 | pmid=9419 ...their [[protein synthesis]]. Azithromycin binds to the 50S subunit of the bacterial [[ribosome]], and thus inhibits [[translation (biology)|translation]] of [[
    15 KB (2,008 words) - 16:46, 27 September 2010
  • ...131919 Pharmacology, Pathology, and Historic Evidence. Clinical Infectious Diseases, 2009; DOI: 10.1086/606060</ref> Aspirin's profitability led to fierce comp ...rin's efficacy as an anti-clotting agent that reduces the risk of clotting diseases.<ref>Jeffreys, ''Aspirin'', pp. 226–231</ref> Aspirin sales revived consi
    78 KB (10,918 words) - 16:52, 27 September 2010
  • ...w medical theories by Thomas Beddoes, that [[tuberculosis]] and other lung diseases could be treated by inhalation of "Factitious Airs"<ref name="Drug discover ...s Beddoes]] in 1798 established the ''"Pneumatic Institution for Relieving Diseases by Medical Airs"'' in [[Clifton, Bristol|Clifton (Bristol)]]. In the baseme
    61 KB (8,728 words) - 16:50, 27 September 2010
  • ...immune system]] and is highest in a healthy gut; it correlates to luminal bacterial load.<ref name="Ann M"/> 3) Surface enterocytes also express high levels of Diseases that result from a homeostatic imbalance include diabetes, [[dehydration]],
    21 KB (3,070 words) - 21:41, 19 September 2010
  • Most commonly, chronic proptosis is caused by [[thyroid]] diseases such as [[Graves disease]]. ...of ophthalmologists and other physicians involved in treating external eye diseases, by disseminating the most current knowledge in the field. The group publis
    8 KB (1,047 words) - 09:39, 20 September 2010
  • # prevent diseases and parasites from entering the hive, and to inhibit bacterial growth<ref>{{cite news ...acid]] and [[chrysin]], with the first three compounds demonstrating anti-bacterial properties.<ref>{{cite journal |author=Qiao Z, Chen R |title=[Isolation and
    18 KB (2,416 words) - 10:07, 20 September 2010
  • ...s on the ground and is affected by the moisture in dew, and by molds and [[bacterial]] action). Modern processes use steam and machinery to separate the fibre, === Diseases ===
    42 KB (6,310 words) - 22:11, 21 September 2010
  • ...e=Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug |volume=42 |issue=1 |pag ...ells (or any cell dependent on synthesizing folic acid) over human cells. Bacterial resistance to sulfamethoxazole are caused by mutations in the folic acid e
    7 KB (978 words) - 13:12, 20 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)